Multi-Pathway
Multi-pathway research panels co-administer multiple peptides engaging distinct receptor classes in a single vial. KLOW blend is the canonical example: Kisspeptin (HPG-axis), Laminin (cell-adhesion), Oxytocin (OXTR central signaling), and GHK-Cu (skin-matrix). Per-component literature applies independently; combined-blend pharmacology is not standardized.
